Edition:
United States

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

991.50DKK
24 May 2017
Change (% chg)

kr.1.50 (+0.15%)
Prev Close
kr.990.00
Open
kr.989.00
Day's High
kr.997.00
Day's Low
kr.989.00
Volume
5,924
Avg. Vol
12,866
52-wk High
kr.1,267.00
52-wk Low
kr.839.00

Select another date:

Tue, May 9 2017

BRIEF-ALK-Abello Q1 EBITDA DKK 140 million

* Q1 TOTAL REVENUE DKK 789 MILLION VERSUS DKK 848 MILLION YEAR AGO

BRIEF-ALK-Abello: Torii submits paediatric registration application for house dust mite SLIT-tablet in Japan

* ALK’s partner, Torii, submits paediatric registration application for the house dust mite SLIT-tablet in Japan

BRIEF-ALK-Abello: FDA approval for HDM sublingual allergy immunotherapy tablet

* Said on Wednesday FDA approved Biologics License Application (BLA) for ALK's house dust mite (HDM) sublingual allergy immunotherapy (SLIT) tablet (ACARIZAX in Europe)

BRIEF-Alk submits registration application for ragweed SLIT-tablet in Europe

* Alk submits registration application for ragweed SLIT-tablet in Europe

BRIEF-Alk Abello Q4 EBITDA ex-items slightly down at DKK 121 million

* Q4 total revenue 754 million Danish crowns ($108.49 million) versus 687 million crowns year ago

Select another date:

More From Around the Web